Literature DB >> 1729285

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

S L Tsai1, P J Chen, M Y Lai, P M Yang, J L Sung, J H Huang, L H Hwang, T H Chang, D S Chen.   

Abstract

T cell proliferative responses to hepatitis B virus-encoded envelope antigen (S + preS2 + preS1), recombinant core antigen (HBcAg), and natural hepatitis B e antigen (HBeAg) were examined in 22 HBeAg-positive patients with chronic type B hepatitis and 17 healthy hepatitis B surface antigen (HBsAg) carriers. The results showed that HBeAg-positive patients had (a) higher levels of T cell responses to HBcAg/HBeAg than those of healthy HBsAg carriers (P less than 0.001 and P less than 0.01, respectively); (b) a further increase in these T cell responses during acute exacerbations (P less than 0.05 and P less than 0.05, respectively); (c) subsidence in the T cell responses to HBcAg/HBeAg after recovery from acute exacerbations and HBeAg seroconversion, whereas the responses would persist at high levels if the patients did not enter a clinical remission; and (d) low levels of T cell responses to S + preS2 + preS1 either before or after HBeAg seroconversion. The appearance of increasing T cell responses to HBcAg/HBeAg usually occurred in the early phase of acute exacerbations. These findings imply that HBcAg/HBeAg-specific T cells play an important role in the exacerbations of chronic hepatitis B and in HBeAg seroconversion. HBcAg/HBeAg-specific precursor T cell frequencies were serially studied in selected cases by limiting dilution assay. Elevation (two- to fourfold) of HBcAg/HBeAg-specific precursor T cell frequencies contributed to the increase of HBcAg/HBeAg-specific T cell proliferation during acute exacerbations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729285      PMCID: PMC442823          DOI: 10.1172/JCI115590

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

Authors:  W F Carman; M R Jacyna; S Hadziyannis; P Karayiannis; M J McGarvey; A Makris; H C Thomas
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

2.  Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg.

Authors:  D R Milich; A McLachlan; A Moriarty; G B Thornton
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

3.  Comparative immunogenicity of hepatitis B virus core and E antigens.

Authors:  D R Milich; A McLachlan; S Stahl; P Wingfield; G B Thornton; J L Hughes; J E Jones
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

4.  Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies.

Authors:  M Mondelli; R S Tedder; B Ferns; P Pontisso; G Realdi; A Alberti
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

Review 5.  Chronic type B hepatitis and the "healthy" HBsAg carrier state.

Authors:  J H Hoofnagle; D A Shafritz; H Popper
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

Review 6.  Relation of the hepatitis B virus carrier state to hepatocellular carcinoma.

Authors:  H Popper; D A Shafritz; J H Hoofnagle
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

7.  Diverse virological, histopathological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.

Authors:  I J Su; M Y Lai; H C Hsu; D S Chen; P M Yang; S M Chuang; J L Sung
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

8.  Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.

Authors:  C M Chu; P Karayiannis; M J Fowler; J Monjardino; Y F Liaw; H C Thomas
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

9.  Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.

Authors:  C Ferrari; A Penna; T Giuberti; M J Tong; E Ribera; F Fiaccadori; F V Chisari
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

10.  Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines.

Authors:  C Ferrari; M U Mondelli; A Penna; F Fiaccadori; F V Chisari
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

View more
  74 in total

Review 1.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeys.

Authors:  Z H Huang; H Zhuang; S Lu; R H Guo; G M Xu; J Cai; W F Zhu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.

Authors:  T Karasawa; T Shirasawa; Y Okawa; A Kuramoto; N Shimada; Y Aizawa; M Zeniya; G Toda
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

Review 4.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.

Authors:  M Sällberg; K Townsend; M Chen; J O'Dea; T Banks; D J Jolly; S M Chang; W T Lee; D R Milich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver.

Authors:  N Obeng-Adjei; D K Choo; J Saini; J Yan; P Pankhong; A Parikh; J S Chu; D B Weiner
Journal:  Cancer Gene Ther       Date:  2012-10-05       Impact factor: 5.987

7.  Spontaneous seroconversion in chronic hepatitis B: role of mutations in the precore/core gene.

Authors:  E Schulte-Frohlinde; G R Foster
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

8.  Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

Authors:  C Boni; A Bertoletti; A Penna; A Cavalli; M Pilli; S Urbani; P Scognamiglio; R Boehme; R Panebianco; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C.

Authors:  P M Yang; L H Hwang; M Y Lai; W L Huang; Y D Chu; W K Chi; B L Chiang; J H Kao; P J Chen; D S Chen
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

10.  No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.

Authors:  Megan Crane; Sunee Sirivichayakul; J Judy Chang; Anchalee Avihingsanon; Sasiwimol Ubolyam; Supranee Buranapraditkun; Pattarawat Thantiworasit; Fiona Wightman; Stephen Locarnini; Gail Matthews; Gregory J Dore; Kiat Ruxrungtham; Sharon R Lewin
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.